Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Start Date
4/14/2025
Completion Date
3/15/2027
Summary
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Eligibility Criteria
Age Range: 22 years to No maximum
Interventions
NEVA VS
Conditions
Locations
Providence St. Joseph Medical Center
Burbank, California 91505
United States
John Muir Health
Walnut Creek, California 94589
United States
Yale
New Haven, Connecticut 06520
United States
Baptist Health South Florida
Miami, Florida 33143
United States
Wellstar Health System
Marietta, Georgia 30062
United States
Endeavor Health
Evanston, Illinois 60201
United States
Univ Iowa
Iowa City, Iowa 52242
United States
Univ Kentucky
Lexington, Kentucky 40506
United States
MaineHealth
Portland, Maine 04102
United States
Mayo Clinic- Rochester
Rochester, Minnesota 55905
United States
Allegheny Health Network
Pittsburgh, Pennsylvania 15222
United States
Geisinger
Wilkes-Barre, Pennsylvania 18711
United States
Valley Baptist Medical Center- Harlingen
Harlingen, Texas 78550
United States
University of Texas Health Science Center at Houston
Houston, Texas 77030
United States
Uni. of Utah
Salt Lake City, Utah 84112
United States
West Virginia University
Morgantown, West Virginia 26505
United States